(Q44183635)

30 November 2017

title

Insulin resistance and its involvement in multiple risk factors associated with type 2 diabetes mellitus (English)

1 reference

30 November 2017

1 reference

1 reference

M Serrano Rios

1

1 reference

30 November 2017

J F Ascaso Gimilio

2

1 reference

30 November 2017

E Blázquez Fernández

3

1 reference

30 November 2017

J Cabezas Cerraro

4

1 reference

30 November 2017

R Carmena Rodríguez

5

1 reference

30 November 2017

F Escobar Jiménez

6

1 reference

30 November 2017

J M Fernández-Real

7

1 reference

30 November 2017

R Gabriel Sánchez

8

1 reference

30 November 2017

R Gomis de Barberá

9

1 reference

30 November 2017

C Grande Aragón

10

1 reference

30 November 2017

J L Herrera Pomba

11

1 reference

30 November 2017

L F Pallardo Sánchez

12

1 reference

30 November 2017

N Potau Vilalta

13

1 reference

30 November 2017

W Ricart Engel

14

1 reference

30 November 2017

A Rovira Loscos

15

1 reference

30 November 2017

A Zorzano Olarte

16

1 reference

30 November 2017

Grupo de Trabajo Resistencia a la insulina de la Sociedad Espanola de Diabetes

17

1 reference

30 November 2017

language of work or name

Spanish

0 references

publication date

1 October 2002

1 reference

30 November 2017

1 reference

30 November 2017

volume

119

1 reference

30 November 2017

issue

12

1 reference

30 November 2017

page(s)

458-463

1 reference

How to measure insulin sensitivity

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973455-6

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973455-6

Dairy consumption, obesity, and the insulin resistance syndrome in young adults: the CARDIA Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973455-6

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973455-6

Continuous infusion of glucose with model assessment: measurement of insulin resistance and beta-cell function in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973455-6

Estimates of in vivo insulin action in man: comparison of insulin tolerance tests with euglycemic and hyperglycemic glucose clamp studies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973455-6

Assessment of insulin sensitivity and beta-cell function from measurements in the fasting state and during an oral glucose tolerance test.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973455-6

Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973455-6

Insulin sensitivity from meal tolerance tests in normal subjects: a minimal model index.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973455-6

A model-based method for assessing insulin sensitivity from the oral glucose tolerance test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973455-6

Insulin resistance and cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973455-6

Coronary Heart Disease Incidence and Cardiovascular Mortality in Busselton with Reference to Glucose and Insulin Concentrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973455-6

Relationship of Glucose Tolerance and Plasma Insulin to the Incidence of Coronary Heart Disease: Results from Two Population Studies in Finland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973455-6

Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973455-6

Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973455-6

U-shaped and J-shaped relationships between serum insulin and coronary heart disease in the general population. The Bruneck Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973455-6

Hyperinsulinemia as an independent risk factor for ischemic heart disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973455-6

Insulin and risk of cardiovascular disease: a meta-analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973455-6

Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973455-6

Multiple CHD risk factors in type 2 diabetes: beyond hyperglycaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973455-6

The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973455-6

Insulin resistance in essential hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973455-6

Insulin resistance is a characteristic feature of primary hypertension independent of obesity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973455-6

Brief review: hypertension in pregnancy : a manifestation of the insulin resistance syndrome?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973455-6

Is type II diabetes mellitus a disease of the innate immune system?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973455-6

Insulin resistance and inflammation in an evolutionary perspective: the contribution of cytokine genotype/phenotype to thriftiness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973455-6

Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973455-6

7 January 2021

The acute phase response

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973455-6

The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973455-6

Insulin is a prominent modulator of the cytokine-stimulated expression of acute-phase plasma protein genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973455-6

Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973455-6

Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973455-6

Increased prevalence of type 2 diabetes mellitus and impaired glucose tolerance in first-degree relatives of girls with a history of precocious pubarche

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973455-6

Polyunsaturated fatty acid regulation of gene transcription: a mechanism to improve energy balance and insulin resistance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973455-6

Dietary carbohydrates and insulin action in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973455-6

Dietary treatment of the metabolic syndrome--the optimal diet.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973455-6

Exercise and insulin sensitivity: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973455-6

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973455-6

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973455-6

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973455-6

Medical significance of peroxisome proliferator-activated receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973455-6

Troglitazone prevents mitochondrial alterations, beta cell destruction, and diabetes in obese prediabetic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973455-6

Treatment of insulin resistance with peroxisome proliferator-activated receptor gamma agonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973455-6

The effect of acarbose on insulin sensitivity in subjects with impaired glucose tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973455-6

Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973455-6

Both a reduced acute insulin response to glucose and lower glucose effectiveness are responsible for the worsening of intravenous glucose tolerance in healthy subjects independently of the degree of obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973455-6

Insulin resistance quantification by fasting insulin plasma values and HOMA index in a non-diabetic population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973455-6

10.1016/S0025-7753(02)73455-6

7 January 2021

Identifiers

DOI

1 reference

30 November 2017

1 reference